Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
94,776,648
-
Share change
-
+5,638,840
-
Total reported value
-
$9,211,930,058
-
Put/Call ratio
-
89%
-
Price per share
-
$97.25
-
Number of holders
-
404
-
Value change
-
+$550,111,004
-
Number of buys
-
222
-
Number of sells
-
176
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2021
As of 31 Mar 2021,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
404 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,776,648 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, STATE STREET CORP, Bank of New York Mellon Corp, Capital International Investors, and PICTET ASSET MANAGEMENT LTD.
This page lists
411
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.